Introduction: Helicobacter pylori (H. pylori) infection has remained as a global health problem. Animal studies demonstrated the role of H. pylori oipA gene in the development of gastric cancer. The aim of this study was the cloning and expression of Helicobacter pylori oipA gene in a bicistronic vector harboring mice IL-18 gene.
Introduction
Helicobacter pylori is a Gram negative, motile, spiral-shaped, and microaerophilic microorganism. This bacterium is one of the most important human pathogens that infect more than half of the population worldwide (1) . H. pylori is a most important causative agent in some gastroduodenal diseases including duodenal ulcer, peptic ulcer, chronic active gastritis, gastric adenocarcinoma, and MALT lymphoma (2) . To date, a number of virulence factors including cagA and vacA genes concerned to severe stomach illnesses such as gastric ulcers and gastric cancer have been identified (3) . Almost 4% of the H. pylori genome encodes outer membrane proteins (OMPs), some of which act as adhesin (4) . OipA (Outer inflammatory protein A) is one of the outer membrane proteins which involve in bacterial adhesion. Several studies showed that the oipA gene is another important virulence factor associated with gastric ulcers and cancer (5) . Interleukin 18 (IL-18) is considered as a pro-inflammatory cytokine and inducer factor of interferon γ (IFN-γ) production by NK cells and CTL (6) . Moreover it also increases Fas dependent cell death (FasDependent Cytotoxicity) and Perforin in these cells. On the other hand, this cytokine plays an essential role in T helper Lymphocyte activities (T helper 1) (7, 8) . Structurally, IL-18 belongs to the super family of IL-1 and is synthesized in inactive and non-secretory precursor form as same as IL-1β (9) . The main characteristic of this cytokine in stimulation of CTL and NK cells and following increased cell killing activity has led to be used in the vaccine research and tumor immunotherapy (10) . Therefore, this cytokine can be used as adjuvant to increase vaccine efficiency especially in DNA vaccine protocols (11) (12) (13) . The importance of OipA in pathogenesis of H. pylori from one side and the adjuvant activity of IL-18 ,especially in TH1 shifting, from other side, persuaded us to design a study to construct a genetic material containing H. pylori oipA and mouse IL-18 genes to assess its immunogenicity in the future investigations.
Material and methods
In order to clone the target genes, H. pylori oipA and murine IL-18, the pIRES2-eGFP vector (Clontech, Takara Bio Company, Shiga, Japan) was applied as expression vector. This bicistronic vector allows the expression of two separate protein from the same mRNA by employing IRES (Internal Ribosome Entry Site) element. As described in previous study, the plasmid Confirmation of cloned DNA: The authenticity of cloned DNA was verified by enzymatic digestion, PCR and sequencing. As shown in Figure 2 the inserted 954 bp fragment was brought out after double digestion with BastXI and NotI. Also 459 bp amplicon was produced by plasmid while added as a template in PCR reaction. Analysis of bidirectional sequencing proved complete accuracy of cloned gene. 
Discussion
Despite great progress in H. pylori vaccine design, the mechanisms of mucosal immunity against this bacterium is unclear up to now. In fact, it is surprising that proteins such as urease and heat shock protein homologues which are present in the cytoplasm of other intestinal pathogens may be serves as vaccines against H. pylori. Successful H. pylori vaccination strategies were evaluated in different animal models by oral administration of H. pylori antigens in combination with mucosal adjuvants such as cholera toxin and E. coli LT enterotoxin. Various antigens have been used as prophylactic or therapeutic H. pylori vaccines in animal models. Chen et al in 2012 reported that injection of the recombinant OipA protein in combination with IL-2 molecular adjuvant and pLTB genes could be effective against H. pylori by reducing the bacterial load in immunized mice (16) . In another study, Chen and colleagues showed that injection of genetic vaccine expressing oipA loaded on attenuated Salmonella typhimurium strain in C57 mice can effectively stimulate cellular and humoral immunity (18 (17) . Due to the ability of IL-18 in stimulation of innate and adaptive immune responses and Th1 shifting, DNA vaccine containing IL-18 molecular adjuvant sounds appealing strategies in preventing of classic and re-emerging diseases (19) . Several advantages have been cited for fusion of murine Fcy2a to cytokines including increased avidity, prolonged circulating half-life due to molecular size increase and reduced renal clearance. Furthermore, fusion with Fc results in alteration of complement-mediated and antibody dependent cell-mediated cytotoxicity, enhancing the effects of IL-18 as a molecular adjuvant (14) .
Considering
OipA virulence and carcinogenesis, the aim of present study was to build a bicistronic plasmid containing codon-optimized H. pylori oipA and murine IL-18 genes to assess immunogenicity of this plasmid in animal models in future studies. Selection of a bicistronic vector enabled us to express both oipA and IL-18 genes from the same construct. Applying two plasmids in DNA vaccine projects can hamper the reproducibility of experiments, so bicistronic vector was used to ensure equal molar ratio of genes (Equimolar) in DNA vaccine formulation in ongoing study. The results of sequencing, transfection and RT-PCR showed that H. pylori optimized oipA gene as well as murine IL-18 were expressed successfully from constructed mIL-18-pIRES2-oipA plasmid in monocytes / macrophages cell line. Moreover, the application of this construct is possible as a promising H. pylori DNA vaccine candidate.
